ERα-/ERβ+ breast cancers belong to the triple-negative breast cancer (TNBC) group, a subgroup of breast cancers characterized by the lack of expression of ERα, progesterone receptor, and human epidermal growth factor receptor-2 (HER-2) [23]. The gene discussed is ESR2; the disease is triple-negative breast carcinoma.